Indefinite Delivery Contract 36E79726D0023
- Not listed
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-oriented federal agency, on June 24, 2025, with an ultimate completion date of June 23, 2030. The contract, valued at $3,747,593.24, establishes a national requirements vehicle for the supply of Lansoprazole 30 milligram capsules in 100-count bottles to multiple federal healthcare systems. The underlying solicitation, issued as a pre-solicitation...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a Federal Supply Schedule contract under General Services Administration (GSA) schedule 61-IB (Pharmaceuticals and Drugs) on June 15, 2023, with an ultimate completion date of June 14, 2028. This multiple-award, non-set-aside contract carries a ceiling value of $5.9 billion and is funded by the Veterans Integrated Service Network 12, a component of the Department of Veterans Affairs (VA). The contract encompasses the supply and...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5), a pharmaceutical manufacturer and distributor headquartered in Camarillo, California, was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain division of the Department of Defense on December 19, 2023. The contract, valued at $10.47 million with an ultimate completion date of December 18, 2028, represents a non-competitive award without set-aside provisions. The contract originated from a pre-solicitation...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5), a pharmaceutical manufacturer and distributor based in Camarillo, California, was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain (Defense) on October 1, 2020, with a ceiling value of $3,657,817.10 and an ultimate completion date of October 13, 2025. This non-set-aside IDV, stemming from a solicitation posted on September 26, 2019 with a due date of January 30, 2020, establishes Golden State Medical Supply...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-oriented federal agency, effective August 29, 2023, with an ultimate completion date of August 29, 2028. The contract, valued at approximately $3.02 million, was not issued under any set-aside designation, indicating competitive procurement. The awardee is a for-profit pharmaceutical manufacturer and distributor headquartered in Calorillo,...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, on May 24, 2021, following a pre-solicitation opportunity posted on August 25, 2020. The contract, valued at $4.55 million with an ultimate completion date of May 23, 2026, carries no set-aside restrictions and reflects the contractor's competitive standing in open federal procurement processes. Golden State Medical Supply...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a Defense-focused federal agency, to manufacture and distribute pharmaceutical products. The contract, with a ceiling value of $51.5 million and an ultimate completion date of September 16, 2025, was awarded on September 17, 2020, following a pre-solicitation posted on September 3, 2019. The originating solicitation sought a national requirements contract for...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, on January 26, 2022, with a ceiling value of $24.4 million and an ultimate completion date of January 25, 2027. This contract represents a standard five-year Indefinite Delivery Vehicle structure typical of federal pharmaceutical procurement programs. The contract carries no set-aside designation, indicating the award was...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, on March 6, 2023, with a ceiling value of $13.44 million and ultimate completion date of March 5, 2028. This contract, categorized under pharmaceutical manufacturing and distribution for the Federal Supply Schedule (FSS), carries no set-aside designation, indicating competitive procurement. The prime contractor is responsible...
- Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on February 20, 2025, to supply Norethindrone Acetate 5mg Tablets to multiple federal healthcare systems. The contract carries a ceiling value of $2,285,266.20 and covers a base period of performance from February 20, 2025, through February 19, 2026, with four one-year option periods extending through February 19, 2027....
Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on May 9, 2026, to supply Simvastatin tablets to multiple federal healthcare agencies. The contract has a ceiling value of $16.8 million and covers a base ordering period from May 9, 2026 through May 8, 2027, with four one-year option periods available. This procurement supports the pharmaceutical supply requirements of the Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Pharmaceutical Prime Vendor Programs. The solicitation, issued in commercial item format under solicitation number 36E79725R0066, encompasses 13 different Simvastatin tablet configurations ranging from 5 milligrams to 80 milligrams in strength, with package sizes of 45, 90, and 1,000 tablets per bottle. Estimated annual usage volumes are substantial, with orders such as over 112,000 bottles of 20-milligram tablets in 90-count packages and approximately 26,874 bottles of 10-milligram tablets in 90-count packages. The contract was procured without set-aside restrictions, reflecting Golden State Medical Supply's competitive standing in open federal pharmaceutical procurement processes. As a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California, the company has been registered in the System for Award Management since 2001 and maintains an extensive portfolio of Indefinite Delivery Contracts with federal agencies for various pharmaceutical products. The successful contractor was required to provide the exact drug name as it appears on the label along with a unique National Drug Code number specific to their organization. This award demonstrates the company's continued capability to provide uninterrupted pharmaceutical supplies to federal healthcare facilities and aligns with the Department of Veterans Affairs' strategy of utilizing prime vendor programs to ensure efficient and reliable medication distribution across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/9/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Simvastatin Tablets (VA-26-00009813) | 36E79725R0066 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 3/10/26, 6:05 PM | |
6505--Simvastatin Tablets (VA-26-00009813) | 36E79725R0066 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 9/26/25, 2:46 PM | |
6505--Simvastatin Tablets (VA-26-00009813) | 36E79725R0066 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 10/31/25, 2:52 PM |